INITIAL COMBINATION THERAPY WITH ADALIMUMAB PLUS METHOTREXATE LEADS TO BETTER LONG-TERM OUTCOMES IN PATIENTS WITH ADVANCED RHEUMATOID ARTHRITIS: ANALYSIS OF THE FINAL 10-YEAR RESULTS OF AN OPEN-LABEL EXTENSION OF A PHASE 3 TRAIL
Author(s):
Keystone, E.C.; Heijde, D. van der; Weinblatt, M.E.; Mozaffarian, N.; Guerette, B.; Kupper, H.; Liu, S.F.; Kavanaugh, A.
